Abstract-Mouse models of thrombosis have extended our understanding of the role of tissue factor (TF) 
T issue factor (TF) is a membrane-bound glycoprotein that is expressed or exposed at sites of vascular injury and is essential for hemostasis. As the initiator of the coagulation system, TF acts as a cofactor for circulating factor VIIa (fVIIa) and starts a series of proteolytic reactions that culminate in the production of the enzyme thrombin, the final effector of the coagulation system.
The cell-based model of hemostasis proposes that cell surface-exposed TF binds circulating fVIIa and generates fXa, which slowly converts prothrombin to thrombin. 1 Thrombin amplifies this process by feedback activation of fV, fVIII, fXI, and activating platelets. Activated platelets provide a surface onto which coagulation complexes assemble, resulting in robust thrombin generation and subsequent fibrin formation. Activated platelets aggregate and fibrin consolidates these aggregates into a thrombus composed of varying proportions of platelets, fibrin, and trapped red cells.
Animal models are useful for studying thrombosis. Although TF initiates thrombosis in most of these models, the cellular source of TF varies depending on the type of injury. TF expressed by cells of the subendothelium initiates clotting if the integrity of the vessel wall is disrupted, such that blood comes into contact with these cells. TF is also present in the circulation. Thus, TF can be detected on activated endothelial cells, 2 hematopoietic cells, [3] [4] [5] and microparticles derived from these cells. 6 -8 Although soluble TF, generated through alternative splicing, can also be found in the circulation, 9, 10 it cannot trigger coagulation because it fails to act as a cofactor for fVIIa. 11 Thus, circulating cellular and microparticle TF provides a mobile blood-borne pool of TF that may contribute to thrombus initiation or expansion. Regardless of the source of TF, thrombosis will only occur if there is sufficient TF to overcome the inhibitory effects of tissue factor pathway inhibitor. 12 To maintain fluidity in the intact vascular system, it is likely that the concentration of blood-borne TF is either below the threshold required to initiate coagulation or in an inactive or encrypted state. Although the exact mechanism of TF decryption is unknown, it may involve the following: (1) phosphatidylserine exposure, 13 (2) TF dimerization, 14 or (3) formation of a disulfide bond between cysteine 186 and cysteine 209 on the extracellular portion of TF that renders it capable of binding fVIIa. 15 All of these processes have been shown to increase TF cofactor activity. Furthermore, protein disulfide isomerase (PDI) has been identified on the surface of TF-expressing cells, where it may facilitate the formation of the disulfide bond. 16, 17 The results of animal models of thrombosis have provided insights into the role of TF in thrombogenesis. Thrombosis in these models is initiated by techniques that induce vascular injury and subsequent TF exposure. Each injury technique provides different information about the contribution of the various sources of TF to thrombosis. However, injury models alone are not sufficient to prove that a particular pool of TF drives clot formation. Instead, inventive genetic models have been developed to explore the importance of a specific source of TF to thrombus formation. For example, cyclization recombination protein (Cre) recombinase controlled by a tissue-specific promoter to remove the TF gene flanked by flox sites 21, 22 has been used to generate mice that lack TF in cardiomyocytes (TF CMϪ/Ϫ , using myosin light chain [MLC]2v-Cre mice), 18 vascular smooth muscle cells (VSMCs) (TF VSMCϪ/Ϫ , using SM22␣-Cre mice), 19 or endothelial and hematopoietic cells (TF Tie2Ϫ/Ϫ , using tyrosine kinase with immunoglobulin-like and EGF-like domains [Tie]2-Cre mice). 20 In addition, the generation of a "low-TF" mouse line that survives with only 1% TF relative to wild type (WT) 23 has also helped delineate the role of TF in thrombosis. This low TF mouse has been used in combination with WT mice to derive mice with reduced TF expression only in hematopoietic cells or with reduced TF only in the vessel wall by using bone marrow transplant strategies. 24 With these genetically altered mice, we can begin to unravel the role of the various pools of TF in hemostasis and thrombosis. This article reviews the contribution of mouse models to our understanding of TF-mediated thrombosis (See Figure and  Table) and highlights the future approaches that can be used to determine the extent to which TF on various cell types contributes to thrombosis in the mouse.
Mouse Models of Thrombosis
To evaluate the role of TF in thrombosis, investigators have used various injury models in WT and TF-altered mice. Thrombosis can be induced in large arteries or veins or in arterioles or venules of the microcirculation, often by damaging the vessel (reviewed by Day et al 25 ) . The injury can be applied from the "outside" by puncture, 26 through-andthrough column laser injury, 27 suture ligation, 28 or the external application of ferric chloride (FeCl 3 ). 29 Injury can also come from the "inside" by systemic administration of inflammatory agents, such as lipopolysaccharide (LPS) 30 ; by generating reactive oxygen species with photoreactive dyes (Rose bengal, Evans blue, or fluorescein isothiocyanate (FITC)-dextran) 31, 32 ; or by focused-laser-delivered heat to the endothelium. Thrombosis can also be induced in arteriovenous shunts, 33 catheter grafts, 34 or vessels by infusion of platelet agonists. 35, 36 These techniques have been reviewed. 37, 38 Certain caveats need to be applied when choosing a model to study the role of TF in thrombosis. First, the mechanism of injury should mimic the disease of interest. For example, TF-positive leukocytes and microparticles are a hallmark of thrombosis associated with cancer 39 or inflammation. 40 Therefore, a study of thrombosis in these settings should use an injury model that causes an increase in these blood elements. Second, TF is not the only activator of the coagulation system. Thus, injury models that increase levels of circulating RNA 41 or polyphosphates 42 or use a catheter to induce thrombosis 43 are likely to trigger coagulation by activating the contact pathway. 35 Consequently, if these injury techniques are used, additional controls are needed to determine the role of TF in thrombus formation. Third, even in models proved to require the extrinsic pathway, the development of a thrombus is not sufficient evidence of TF-dependent thrombin generation and fibrin formation because platelet thrombi can form in the absence of fibrinogen. 44 Measures of TF activity should include an assessment of TF-dependent thrombin activity, such as fibrin formation or thrombin-dependent platelet activation. To minimize these problems, it is important to do the following: (1) use an injury Figure. The sources of TF in thrombus formation in different injuries. TF can be found on subendothelial cells; activated endothelial cells; circulating hematopoietic cells, including leukocytes (large light blue); activated platelets (dark blue); and microparticles (small light blue). The importance of TF to each of the injury models is indicated by the font size of "TF." Top, Hematopoietic cell-derived TF is more important than vessel wall TF in the laser injury of the cremaster arteriole, where the endothelium remains largely intact. Middle, In contrast, the Rose bengal injury of the carotid (and likely the FeCl 3 injury) causes denudation of the endothelial layer and exposes subendothelial TF. Bottom, Vessel wall TF appears to be even more important in skin puncture injury.
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Tissue Factor and Thrombosismodel that results in TF-driven thrombosis and (2) provide evidence that TF neutralization attenuates thrombosis in the model. Last, the importance of TF from specific cells may change over time because of injury 45 or inflammation-induced 46 TF gene expression. With these caveats in mind, we will review the various injury models and describe what they have contributed to our understanding of TF in thrombosis.
Ligation
Ligation provides a useful model of stasis-associated thrombosis. 28 Although this model is often used to investigate mechanisms of deep vein thrombosis (DVT), it also has been applied to arteries. 16, 47 
Venous Ligation Models
Typically, the inferior vena cava (IVC) is ligated to cause complete or partial stasis. Depending on the study, a single or double ligature is used. Side branches that feed the IVC may also be tied to ensure complete cessation of blood flow. 37 IVC ligation-induced thrombosis is reduced by andrographolide, a p50 inhibitor. 48 Andographolide blocks nuclear factor-B-induced TF expression in endothelial cells and leukocytes, suggesting that the nuclear factor-B transcription factor, p50, is important in the pathogenesis of DVT. Recently, Zhou et al 49 measured the extent of thrombus formation 15 and 60 minutes after IVC ligation in rats. Even after 15 minutes, thrombi were detected. These thrombi contained fibrin, platelets, and red blood cells, along with the occasional leukocyte. Furthermore, immunohistochemical staining revealed TF, PDI, and P-selectin within the thrombus, with most of the TF and the PDI colocalized to the leukocytes. 49 Studies that used chimeras of low-TF bone marrow transplanted into WT mice and WT bone marrow transplanted into low-TF mice demonstrated that thrombus formation is independent of hematopoietic TF after a 48-hour single IVC ligation injury. 24 The apparent incongruity of these studies may be explained by the fact that the mere presence of TF antigen on hematopoietic cells within a thrombus does not prove that this TF contributes to thrombus growth. Instead, these results suggest that circulating TF, although present, is not abundant or active enough to overcome tissue factor pathway inhibitor in this injury model.
Although hematopoietic TF does not contribute to thrombus formation, the IVC ligation injury model has been shown to be dependent on P-selectin. 28 However, demonstration that a thrombosis model is P-selectin dependent does not necessarily imply TF microparticle delivery. P-selectin on activated platelets induces endothelial cell von Willebrand factor (vWF) secretion, which may also augment thrombosis, 50 without a requirement for TF.
Arterial Ligation Models
Carotid artery ligation for 5 minutes induces thrombus formation. 16 The injection of TF-positive microparticles enhances fibrin formation in this model. This enhancement is abolished when the microparticles are premixed with an antibody against TF, 16 suggesting that circulating TF may contribute to thrombus expansion in this model. However, the infusion of TF microparticles likely exceeds the endogenous circulating levels of this particular source of TF in vivo. Therefore, care must be taken to interpret the physiological relevance of these results. The infusion of an anti-PDI antibody also abolished the enhanced thrombus formation, suggesting that PDI-induced TF decryption may play a role in 84 Ab to TF inhibits thrombus formation 67 TF in histological sections 19 TF in histological sections 24 TF in histological sections 49 and thrombus formation is blocked by NF-B inhibitor 48 Low-TF mouse Cardiac fibrosis 23 Decreased thrombus formation 7 NR NR Delayed occlusion 24 Decreased thrombus size 24 Low A summary of the known data regarding the role of TF in thrombus formation using the low-TF mouse, cardiomyocyte TF-deficient mouse (TF flox/flox /MLC2v-Cre), vascular SM cell TF-deficient mouse (TF flox/flox /SM22␣-Cre), hematopoietic and endothelial cell TF-deficient mice (TF flox/flox /Tie2-Cre), or the hTF mouse. Wild-type and low-TF mouse chimeras were also made by transplanting bone marrow from one into the other to investigate the role of hematopoietic cell TF to thrombus formation in each injury model.
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Arterioscler Thromb Vasc Biol May 2010 thrombosis in this model. 16 An anti-PDI antibody also reduced fibrin formation in response to wire-induced endothelial denudation. However, it remains uncertain whether thrombosis in this model is driven by TF or contact pathway activation by the wire. The use of a neutralizing TF antibody would have helped to clarify this issue.
Ferric Chloride
In this injury model, an FeCl 3 -soaked filter paper is applied to the exterior of a blood vessel. 37 This model is thought to mimic a mechanical injury because FeCl 3 causes denudation of endothelial cells, 51 thereby exposing the subendothelium, including collagen. 29 However, because FeCl 3 is an oxidizing agent, the potential impact of oxidation of extracellular components needs to be considered before directly extrapolating the findings to catheter-related mechanical injury. Furthermore, the extent of thrombus formation after FeCl 3 application to the adventia can be highly variable, 52 which may limit our interpretation of results using this technique because the extent of vessel wall TF exposure is not necessarily consistent between reports. Knockout mice and pharmacological agents have been used to characterize the components of the coagulation system that participate in thrombus formation after FeCl 3 -induced injury. 37 Prolonged times to occlusion were observed in mice deficient in fIX, 53 fXI, 53 or fXII. 35 Also, inhibitors of thrombin, 54 fIXa, 55 or fXa 56 prolonged times to occlusion in WT mice after FeCl 3 injury. Inhibitors of specific platelet receptors also prolonged the time to occlusion; these included inhibitors of glycoprotein VI (GPVI), 57 ␤ 3 , 58 P2Y 12 , 59 or P2Y 1 59 (but not P2X 1 59 ). Modulation of platelet signaling molecules, such as phosphatidylinositol 3-kinase␥, 60 phospholipase C␤, 60 Rap1b, 61 or p38␣ 62 (by P2Y 12 63 or ␣ IIb ␤ 3 antagonists 56, 64 ) also prolonged the time to occlusion. These data further support the important role that collagen and thrombin play in carotid artery occlusion after FeCl 3 injury. Although TF is likely to be a major contributor to thrombus formation and growth, delineation of its contribution relative to other initiators is complicated.
In the microcirculation, FeCl 3 -induced thrombus growth is monitored by using fluorescence microscopy to follow the accumulation of fluorescently labeled platelets transfused into the mouse before injury; fibrin deposition is not usually assessed. The occlusion of arterioles is delayed or inhibited when (1) vWF, 44 fibrinogen, 65 the collagen receptor GPVI/Fc receptor ␥ (FcR␥), 66, 67 or thrombin receptors 68 are deficient; or (2) TF 67 or thrombin 66 is inhibited. Collectively, these data suggest that platelet accumulation after FeCl 3 injury to the microcirculation is dependent on both thrombin and collagen. At least in this model, collagen provides a TF-independent mechanism of thrombus formation, which must be considered whenever an FeCl 3 -induced injury is used.
Platelet adhesion after FeCl 3 injury is more rapid in mesenteric venules than in arterioles. 67 FeCl 3 likely diffuses more rapidly through the wall of venules than arterioles; however, there may be other explanations for this finding. In venules, thrombus formation is delayed, but not completely inhibited, when WT mice are given an anti-TF antibody or when mice are lacking a collagen receptor (FcR␥). 66 Thus, collagen exposure and TF-induced thrombin generation both contribute to platelet accumulation in venules. However, the authors did not examine whether fibrin or TF was present within the thrombus. 66 Nevertheless, these results suggest that the contribution of TF to platelet accumulation may be more dependent on the type of injury than on the type of blood vessel that is injured. Taken together, these data support the concepts that (1) FeCl 3 injury to the microcirculation causes collagen-dependent thrombus formation and (2) FeCl 3 injury in arterioles induces robust TF-dependent thrombin generation and fibrin formation. Thrombus expansion in venules after FeCl 3 injury is comparatively less dependent on TFstimulated thrombin generation.
Compared with WT mice, TF VSMCϪ/Ϫ mice exhibit impaired, but not absent, thrombus formation in the carotid artery after FeCl 3 -induced injury. 19 The proportions of thrombus-associated TF, fibrin, and platelets, assessed in histological sections, were similar to those in WT mice. 19 These observations suggest that vascular smooth muscle TF contributes to thrombus formation after FeCl 3 -induced injury, but is not the only procoagulant stimulus in this injury model. Previous reports have demonstrated that FeCl 3 induces RNA release into the circulation, which contributes to occlusive thrombus formation. 41 Therefore, the relative contributions of vessel wall-released RNA and circulating and/or endothelial TF to residual thrombus formation and expansion need to be evaluated using this injury technique. A comparison of time to occlusion in low-TF and WT mice after FeCl 3 injury would be informative.
Skin Puncture
The skin puncture vascular injury technique has not been widely used to study the role of TF. Skin puncture is useful for measuring the coagulation response to traumalike injury, in which vessels are severed. Skin puncture is a unique form of injury because it avoids endothelial cell damage by chemicals or the application of heat. Consequently, skin puncture may provide a model of hemostasis versus thrombosis.
Although TF was found within the thrombus after FeCl 3 injury to the saphenous vein, TF was not detected within the clots that formed after skin puncture. 69 These results may suggest that accumulation of hematopoietic cell-derived TF in a growing thrombus requires extended exposure to flowing blood, in which circulating TF has a greater opportunity to become entrapped in the growing thrombus. Understanding the differences between skin puncture and other injury models may be useful in predicting a role for hematopoietic TF in hemostasis.
Photoreactive Dyes
Photoreactive dyes include Rose bengal, Evans blue, and FITC-dextran. Rose bengal is a photoreactive dye that accumulates in the membrane of vascular endothelial cells and generates reactive oxygen species when exposed to light at a wavelength of 543 nm. 31 Rose bengal injury is used to mimic arterial thrombosis in response to atherosclerotic plaque rupture, because it creates a mild form of oxidative injury. However, the injury induced by photoactivation of Rose bengal may not be restricted to the illuminated region. Thus, transmission electron microscopy demonstrates damaged and
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highly vacuolated endothelial cells extending beyond the illuminated area of the vessel, likely because of the diffusion of the activated photochemical. 70 Other photoreactive dyes have also been used to induce injury. An electron microscopic evaluation after FITC-dextran photoactivation demonstrates injured, but not denuded, microvascular endothelium, 71, 72 similar to what is found with Rose bengal. 70 Evans blue, activated by a laser, causes endothelial denudation in the microcirculation, but not in the carotid artery, suggesting that this method causes different injuries in different-sized vessels. 32 These differences likely reflect the reduced penetrance of the laser in the carotid artery compared with the microcirculation and presumably the venous system. Rose bengal injury of the carotid artery is often touted as the model that best resembles thrombosis in the setting of atherosclerosis. 37 However, care must be taken to ensure that atherosclerosis is present in the vessels under evaluation to properly recapitulate the inflammatory conditions present at sites of atherothrombosis. 73 Studies using Rose bengalinduced injury have demonstrated that inhibitors of thrombin, fXa, or platelet integrins prolong the time to occlusive thrombus formation. 74 , 75 Day et al 24 demonstrated that the time to occlusion after Rose bengal injury to either the carotid artery or the IVC was prolonged in low-TF mice compared with WT mice. By using a bone marrow transplant strategy, the time to occlusion in either vessel was not accelerated when low-TF mice were transplanted with WT bone marrow. 24 Similarly, the time to occlusion was not prolonged when low-TF bone marrow was transplanted into a WT mouse. 24 These data suggest that vessel wall TF is the major contributor to occlusive thrombus formation in this injury model, similar to results obtained using the IVC ligation model.
Photoreactive Dye Injuries in the Setting of Inflammation
In a murine experimental colitis model, inflammation (induced by dextran sodium sulfate feeding) shortened the time to occlusive thrombus formation in cremaster arterioles after FITC-induced injury. 76 A murine antibody directed against TF normalized the time to occlusion and decreased blood cell recruitment and tissue injury caused by the inflammation. 76 These data suggest that TF is an important link between inflammation and coagulation. The cellular source of TF that contributes to the interaction between coagulation and inflammation remains unknown; however, monocytes 77 and endothelial cells are likely candidates. In a model of light/dye-induced injury to cremaster venules, the presence of LPS accelerated the time to occlusion in both WT and P-selectin-deficient mice, but had no effect on occlusion time in vWF-deficient mice. 78 Therefore, vWF, but not P-selectin, is essential for LPS-enhanced thrombosis in this venule dye injury model. The critical role for vWF in this model likely reflects the increased vWF expression in response to LPS. 78 These data suggest that even though circulating TF may be enhanced by LPS, 79, 80 the delivery of hematopoietic cell-derived TF by P-selectin is not important for clot formation in light/dye-induced injury and presumably all models in which vessel wall TF is exposed.
Laser
The laser injury model has been used to recapitulate thrombosis in the setting of inflammation or as a consequence of endothelial dysfunction because thrombosis occurs without endothelial denudation, a situation akin to coagulopathy in the setting of inflammation. 81 Much of the work on TF with this model has used a focused laser, characterized by Rosen et al, 70 to deliver energy to a focal spot. This is in contrast to previous descriptions of laser-induced thrombosis, in which the laser energy was delivered as a column of energy, thereby disrupting cells of the adventia and the circulation in addition to the endothelium. 27, 82 By using the current laser technology, the injury can be delivered such that it does not result in endothelial cell denudation. 70 However, because the extent of damage depends on the duration, intensity, and location of the laser energy that is delivered, 70 some investigators have empirically differentiated minimal injuries from larger injuries. 83 Because a thick vessel wall limits the energy penetration of the laser beam, this model has mostly been applied to the study of superficial vessels in the microcirculation. Intravital microscopy has been used to image various components of the thrombus in vivo using a fluorescent marker, often an antibody. 84 To put into context what we have learned about TF from focused-laser arterial injuries, it is important to understand the requirement for platelet accumulation in this model. Platelet accumulation (as measured by accumulation of a fluorescent antibody to the ␣ IIb -integrin in platelets) requires thrombin because platelet deposition is abolished or attenuated if thrombin is inhibited with hirudin. 66 Likewise, platelet accumulation is attenuated if laser injury experiments are performed in mice that are deficient in protease-activated receptor (PAR)-4, 85 fVIII, 86 fIX, 86 or fXI. 87 In contrast, platelet accumulation is unaffected by deficiencies in the collagen receptor GPVI, 66 FcR␥, or vWF. 88 These findings imply that thrombin formation is required for platelet accumulation in an arteriole laser injury. In venules, thrombus formation is only partially inhibited by phe-pro-arg-chloromethylketone (FPRck), a thrombin inhibitor, suggesting that additional factors contribute to thrombus formation after focused-laser injury in the venous system. 70 In contrast, FPRck completely inhibited thrombus formation after Rose bengal injury of the venous system, 70 highlighting important differences in thrombin generation after Rose bengal injury compared with focused-laser injury.
By using intravital microcopy, WT mice exhibit platelet, TF, and fibrin accumulation within minutes of laser injury to cremaster muscle arterioles. 84 TF accumulates in the upstream portion of the thrombus as the thrombus expands, consistent with binding of circulating TF. 84 TF accumulation and the associated fibrin formation is dependent on P selectin glycoprotein ligand-1 (PSGL-1) and P-selectin interactions because TF and fibrin accumulation are reduced in P-selectin or PSGL-1-deficient mice or if a P-selectin neutralizing antibody is given to WT mice. 89 Activated platelets express P-selectin on their surface, which binds to PSGL-1 on leukocytes, resulting in TF expression 90 and an increase in the number of TF-bearing microparticles. 6 However, P-selectin alone may not account for the increase in TF expression, suggesting a cooperative mechanism that involves other, yet
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to be identified, factors. 91 Interestingly, the budding of TF-positive microparticles from monocytes occurs hours after platelet P-selectin binds PSGL-1 in vitro, 92 suggesting that microparticle TF is not generated for immediate use. These data imply that a complex interaction between platelets and monocytes induces the release of microparticle TF, which accumulates within a developing thrombus at subsequent injury sites. This phenomenon may be especially relevant in chronic inflammatory states or in sepsis, where the monocyte count is typically high. 93 The importance of monocyte TF may be underrepresented in the focused-laser injury model because LPS induces stronger TF expression by monocytes than does platelet P-selectin. 90, 91 Thus, future experiments should look at laser injury models in the context of sepsis or LPS infusion.
Cremaster arteriole laser injury in low-TF mice resulted in reduced platelet accumulation and minimal fibrin deposition compared with that observed in WT mice. 7 In direct contrast to Rose bengal carotid artery and IVC ligation injury models, chimeras of low-TF bone marrow transplanted into WT mice also exhibited reduced platelet accumulation and fibrin deposition after focused-laser injury. 7 Interestingly, fibrin formation was comparable to that in WT mice in the early phase but was reduced in the late phase of thrombus formation. 7 These data suggest that nonhematopoietic TF has a role in the early stage of thrombus formation, whereas the accumulation of hematopoietic cell-derived TF is important at later stages of the injury response. 7 Consistent with this concept, chimeras of low-TF mice transplanted with WT bone marrow exhibited reduced platelet accumulation and reduced fibrin accumulation at the early stages of thrombus development, which normalized relative to WT mice at later stages of thrombus formation. 7 These data suggest that the accumulation of circulating TF can correct the deficiencies in thrombus formation observed at the earlier time point. Interestingly, TF accumulation was detected immediately after focused-laser injury in low-TF mouse/WT bone marrow chimeras. 7 These data suggest that thrombus-associated TF must be the result of binding of circulating TF and not direct membrane transfer between leukocytes and platelets because leukocytethrombus interactions do not begin to occur until 2 to 3 minutes after injury, well after microparticle accumulation occurs in this model. 94 In a recent study, 20 TF VSMCϪ/Ϫ mice exhibited similar fibrin accumulation in thrombi compared with Cre-negative controls. In the same report, TF Tie2Ϫ/Ϫ mice, which have a 93% reduction in circulating TF, had impaired platelet and fibrin accumulation in thrombi compared with Cre-negative controls. 20 This preliminary report adds further support for the role of circulating TF in the focused-laser injury model.
Despite data supporting a role for hematopoietic TF in thrombus formation and expansion in the focused-laser injury model, several important questions remain unanswered. In low-TF mice transplanted with WT bone marrow, the ratio of TF to platelets in the early phase of thrombus growth was elevated relative to WT controls. 7 The investigators reported that this was likely because there are fewer platelets in the thrombi of low-TF mice. 7 However, if P-selectin is required to recruit TF-containing microparticles, why are TF levels not proportionally decreased within a thrombus containing fewer platelets? Also, a role for platelet TF has not been excluded in this model. Testing for the presence of platelet TF in the TF Tie2Ϫ/Ϫ mice may be useful. Similarly, a role for TF in "young" endothelial cells, 95 which could be derived from circulating endothelial progenitor cells after the bone marrow transplant, has not been investigated.
Although hematopoietic TF is present in the thrombus after focused-laser injury of the cremaster arteriole, the question remains whether it is actively participating in thrombus formation. To begin to address this issue, Cho et al 17 demonstrated the presence of PDI within the thrombus, a possible activator of encrypted TF. The inhibition of PDI activity with bacitracin or a PDI-neutralizing antibody inhibits platelet accumulation and fibrin deposition. 17 Interestingly, PDI inhibition also blocks the formation of a platelet or fibrin thrombus in PAR-4 -deficient mice, 17 raising the possibility that PDI influences thrombus formation independent of thrombin generation. However, important controls were not reported in this study. For example, does PDI influence thrombus formation in a TF-independent manner in vivo? Other potential substrates of PDI were not considered in these studies and should be accounted for. Testing PDI inhibitors in WT mice containing low-TF bone marrow would be informative. These data, together with bone marrow transplant data in low-TF mice, 7 demonstrate that the accumulation of hematopoietic cell-derived TF and TF deencryption are critical to platelet accumulation and fibrin formation in this injury model. However, experiments should be repeated using the TF VSMCϪ/Ϫ to decisively exclude a role for vessel wall TF in this model. Also, the potential role of endothelial TF should also be evaluated.
Graft or Catheter Thrombosis
Medical instruments, such as stents, catheters, and grafts, have been shown to induce thrombosis because of the activation of contact factors fXII and prekallikrein (reviewed by Tang and Hu 96 ). As a result, graft or catheter-induced thrombosis is not thought to be dependent on TF activity. 97 However, an anti-P-selectin antibody, which blocks leukocyte/platelet interactions, reduced fibrin formation on polyethylene terephthalate (Dacron) grafts in an arteriovenous shunt model in baboons. 33 Although neither TF nor circulating microparticles were enumerated in this landmark study, this finding raises the possibility that blood-borne TF is involved in catheter-related thrombosis. Supporting this conclusion, a TF-neutralizing antibody given to rabbits reduced thrombus formation that was induced by either a silicone vein shunt or a collagen-coated thread in the jugular vein. 98 Interestingly, Gruber and Hanson 99 demonstrated that the inhibition of fXI prevented occlusive thrombus formation in both TF-coated and uncoated Dacron grafts in baboons. These results suggest that fXI may contribute to thrombus expansion in TF-stimulated coagulation, drawing an important connection between TF-stimulated coagulation and components upstream in the coagulation system.
Infusion of Platelet Activators
None of the models previously discussed have addressed the possible contribution of platelet-derived TF to thrombus 
Conclusion and Unifying Model
TF is essential for hemorrhage-free survival. When the heart, lung, and brain are lacking TF, bleeding occurs. Thus, TF is required for hemostasis in its simplest form (ie, to maintain the integrity of a high-pressure circulatory system). A lack of TF in specific tissues would likely also lead to hemorrhaging, although whether this occurs spontaneously or not would depend on the tissue and the stressor to it. The role of TF in pathological thrombosis is more complex. Data from the thrombosis models presented herein suggest that vessel wall TF is the major procoagulant force driving thrombus formation when the endothelium is disturbed. On the other hand, when thrombosis occurs without vessel rupture and limited endothelial denudation, what initiates coagulation? TF exposure on endothelial cells can occur, 101 but its requirement has not been demonstrated in a thrombosis model. Furthermore, the requirement for platelet and/or monocyte TF has not been adequately proved in a thrombosis model. To determine the role of a specific cellular source of TF to thrombus formation in an injury model, the following must occur: (1) experiments must carefully exclude all other potential sources of TF and (2) tissue factor activity on the cell of interest must be sufficient to overcome the threshold imposed by tissue factor pathway inhibitor. These criteria were barely satisfied when demonstrating a role for hematopoietic TF in the laser-induced cremaster muscle arteriole. 7, 20 However, inconsistencies within the report weaken the conclusions. These criteria were successfully satisfied in studies evaluating a role for vascular smooth muscle cells in the FeCl 3 injury of the carotid. 19 Models of thrombosis will need to satisfy this same paradigm to demonstrate a role for TF in other cells, such as platelets and endothelial cells, that are still controversial sources of TF. Mice lacking TF in either their endothelial cells or platelets might not satisfy these parameters in any current thrombosis model, necessitating the development of novel mice strains to address the role of TF in these cell types. Thus, the Cre/flox/ flox system used in the development of the TF CMϪ/Ϫ , 18 TF VSMCϪ/Ϫ , 19 and TF Tie2Ϫ/Ϫ 20 will be useful technology for the future. Furthermore, a recently described mouse expressing WT levels of human TF 102 may be useful for testing an extensive library of TF-directed antibodies, 103 as will inhibitory antimouse TF antibodies. 104 Also, small and interfering RNA might be useful to study the temporal requirements of TF in animal models.
In conclusion, proving the importance of TF in different cell types in the mouse has not been straightforward. Inventive genetic approaches and thrombosis models have provided data; however, these data need to be carefully interpreted before clear conclusions can be made. With anticipation, we wait for reports clarifying the roles of TF in microparticles, platelets, and endothelial cells in thrombus formation.
